ketotifen has been researched along with Conjunctivitis in 7 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Conjunctivitis: INFLAMMATION of the CONJUNCTIVA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The results of this study suggest that emedastine and ketotifen are not significantly different with respect to anti-itching efficacy in the CAC model of acute allergic conjunctivitis." | 5.10 | Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model. ( Bensch, G; D'Arienzo, PA; Leonardi, A, 2002) |
| "Olopatadine is more effective than ketotifen in reducing the itching associated with allergic conjunctivitis in the antigen challenge model." | 5.09 | A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model. ( Bensch, G; Berdy, GJ; Berdy, SS; Brusatti, RC; Spangler, DL, 2000) |
| "1% Ketotifen ophthalmic preparation was evaluated in 11 cases of conjunctivitis due to Japanese cedar pollinoisis (three cases also associated with vernal catarrh)." | 5.05 | Therapeutic effects of a new, anti-allergic ophthalmic preparation. ( Arai, Y; Fujiwara, T; Kubota, A; Mikuni, I; Mizushima, N; Mochida, H; Togawa, K, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dennis, M | 1 |
| Maoz, A | 1 |
| Hughes, D | 1 |
| Sanchorawala, V | 1 |
| Sloan, JM | 1 |
| Sarosiek, S | 1 |
| Blondin, C | 1 |
| Cholley, B | 1 |
| Haeffner-Cavaillon, N | 1 |
| Goldschmidt, P | 1 |
| Mikuni, I | 2 |
| Sato, K | 1 |
| Togawa, K | 2 |
| Mizushima, N | 2 |
| Fujiwara, T | 1 |
| Mochida, H | 1 |
| Arai, Y | 1 |
| Kubota, A | 1 |
| Mancel, E | 1 |
| Drouet, M | 1 |
| Sabbah, A | 1 |
| Berdy, GJ | 1 |
| Spangler, DL | 1 |
| Bensch, G | 2 |
| Berdy, SS | 1 |
| Brusatti, RC | 1 |
| D'Arienzo, PA | 1 |
| Leonardi, A | 1 |
1 review available for ketotifen and Conjunctivitis
| Article | Year |
|---|---|
[Membrane stabilizers (chromones and ketotifen)].
Topics: Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Cell Membrane; Conjunctivitis; Cromoly | 1999 |
3 trials available for ketotifen and Conjunctivitis
| Article | Year |
|---|---|
Therapeutic effects of a new, anti-allergic ophthalmic preparation.
Topics: Animals; Clinical Trials as Topic; Conjunctivitis; Humans; Hypersensitivity; Ketotifen; Ointments; P | 1982 |
A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model.
Topics: Allergens; Anti-Allergic Agents; Antigens; Conjunctivitis; Dibenzoxepins; Double-Blind Method; Human | 2000 |
Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model.
Topics: Allergens; Anti-Allergic Agents; Benzimidazoles; Conjunctivitis; Double-Blind Method; Eye Color; Fem | 2002 |
3 other studies available for ketotifen and Conjunctivitis
| Article | Year |
|---|---|
Bortezomib ocular toxicities: Outcomes with ketotifen.
Topics: Adult; Aged; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Chalazion; Con | 2019 |
[In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
Topics: Air Pollutants; Anti-Allergic Agents; Benzalkonium Compounds; Benzimidazoles; Complement Activation; | 2003 |
A quantitative tear fluids determination of therapeutic efficacy for allergic conjunctivitis.
Topics: Adult; Child; Conjunctivitis; Female; Humans; Ketotifen; Male; Refractometry; Rhinitis, Allergic, Se | 1984 |